Statement on Novogene Erroneously Listed on 1260H List
BEIJING, June 20, 2026 /PRNewswire/ -- On June 8, 2026, the U.S. Department of Defense (DOD) erroneously designated Novogene Co., Ltd. on its Section 1260H list under the National Defense Authorization Act for Fiscal Year 2021. This designation is...
Asia Pacific Travellers Seek Familiarity, Practicality, Flexibility Amid Shifting Global Dynamics: Visa Report
Visa's 2026 Global Travel Intentions study shows how Asia Pacific travellers seek trusted destinations, plan with greater intent, and seek flexibility to navigate global uncertainties SINGAPORE, June 16, 2026 /PRNewswire/ -- Visa, a global leader in...
56% Want It, 38% Leave For It: The Critical State of Work-Life Balance in Hong Kong: Randstad Hong Kong
Work-life balance remains the #1 Employee Value Proposition (EVP), jumping 10% in importance since 2024 (56% in 2026 vs. 46% in 2024). Top 3 turnover drivers: Poor work-life balance, uncompetitive compensation & benefits, and limited career...
China Daily: China-US ties seek a path beyond confrontation
BEIJING, May 22, 2026 /PRNewswire/ -- This is a news report by China Daily: Scholars at a China Daily seminar said the recent summit between President Xi Jinping and US President Donald Trump in Beijing pointed to a realistic goal of keeping rivalry...
MALAYSIA HEALTHCARE RETURNS TO MEDAN AS INDONESIAN PATIENTS SEEK TRUSTED SECOND OPINIONS ABROAD
MEDAN, Indonesia, April 25, 2026 /PRNewswire/ -- Malaysia has steadily emerged as one of the most trusted destinations for Indonesian patients seeking timely and reliable care. Following its last major outreach in 2022, Malaysia Healthcare returns...
Xinhua Silk Road: Chinese baijiu maker convenes meeting to seize chances in changing market
BEIJING, Dec. 22, 2025 /PRNewswire/ -- When disruptive changes redefined market demand in the past days of 2025, Chinese baijiu producer Wuliangye convened recently its annual convention to seek consensus for navigating the changing liquor market....
DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT
Recruitment successfully completed in Dimerix' ACTION3 Phase 3 clinical trial[1], which has recruited and dosed its target 286th adult patient The ACTION3 Phase 3 trial explores the efficacy and safety of DMX-200 in FSGS patients when dosed in...
Global Brands Turn to Shoplazza as Platform Reliability Becomes Top Priority
As commerce platforms face instability, merchants are choosing Shoplazza for its proven dependability, dedicated support, and seamless transitions. TORONTO, Dec. 14, 2025 /PRNewswire/ -- Shoplazza, a leading commerce platform for DTC brands, is...
Beijing Review: Harmony over hubris
BEIJING, Dec. 12, 2025 /PRNewswire/ -- Humanity finds itself today at a nodal point in world history, as German philosopher G.W.F. Hegel would call it. We are in the earliest stages of a leap that will mark an era for history books in the future. A...
Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner
SYDNEY, Oct. 27, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") today announced its intention to request and hold a follow-up Type C meeting with the U.S. Food & Drug Administration (FDA) to discuss overall survival...